Oncology Consortium

Impactful Education Through Innovative Engagement

roy.berger@theoncologyconsortium.com | (516) 729-0303

James O. Armitage, MD

Leukemia, Lymphoma, And Myeloma Oncology Consortium

Dr. James O. Armitage, a graduate of the University of Nebraska Medical Center, completed his internship and residency in Internal Medicine at Nebraska, a fellowship in Hematology/Oncology at the University of Iowa and a brief stint in private practice in Omaha. He developed and directed the Bone Marrow Transplant program at the University of Iowa and later at the University of Nebraska. At Nebraska he served as Vice-Chair of Internal Medicine, Chief of the Section of Oncology and Hematology, Chair of the Department of Internal Medicine, and Dean of the College of Medicine. He currently is The Joe Shapiro Professor of Medicine at the University of Nebraska Medical Center. Dr. Armitage is board certified in Internal Medicine, Medical Oncology, and Hematology, and a Fellow of both the American and Royal College of Physicians and of the American Association for the Advancement of Sciences. He has served on many national/international oncology committees including the United States National Cancer Advisory Board and the French National Cancer Advisory Board. He is past president of both the American Society of Clinical Oncology and the American Society of Blood and Marrow Transplantation. He has served on the Scientific Committee of the International Congress on Anti-Cancer Treatment in Paris, France, the International Symposium on Hodgkin Lymphoma in Cologne, Germany and the International Conference on Malignant Lymphoma in Lugano, Switzerland.


Sergio A. Giralt, MD

Leukemia, Lymphoma, and Myeloma Oncology Consortium

Sergio A. Giralt, MD is the Chief of the Adult Bone Marrow Transplant Service in the Division of Hematologic Oncology at Memorial Sloan Kettering Cancer Center in New York, New York. He is affiliated with Weill Cornell Medical College as a Professor of Medicine. He received his medical degree from Universidad Central de Venezuela in Caracas, Venezuela, and completed his postgraduate internship at the University Hospital of Caracas. He also completed an internal medicine residency at Good Samaritan Hospital in Cincinnati, Ohio and a postdoctoral fellowship in hematology and oncology at The University of Texas MD Anderson Cancer Center.


Andre Goy, MD

Leukemia, Lymphoma, And Myeloma Consortium

Andre Goy, MD is the Chairman and Director of the John Theurer Cancer Center at Hackensack University Medical Center, as well as the Lymphoma Division Chief. He is the Chief Science Officer and Director of Research and Innovation of Regional Cancer Care Associates. Dr. Goy also holds the title of Professor of Medicine, Georgetown University. Dr Goy, completed his medical training in France then joined Sloan Kettering Institute for a post-doc in molecular oncology before his appointment at Weill Cornell Medical College and joining Memorial Sloan Kettering Cancer Center as attending in the Lymphoma Service. Dr. Goy then joined MD Anderson Cancer Center in Houston as faculty on the Lymphoma Service and as assistant professor at the University of Texas. He was appointed at John Theurer Cancer Center in 2005 as Chief of Lymphoma before becoming Deputy Director and now Chairman and Executive Director of the cancer center. He has published more than 100 articles and serves as reviewer for a number of journals including Journal of Clinical Oncology, Blood, Cancer and Clinical Cancer Research among others. Dr Goy is also the Editor-in-Chief of Oncology & Biotech News.


Steven Horwitz, MD

Leukemia, Lymphoma, and Myeloma Oncology Consortium

Dr. Steven Horwitz is a medical oncologist who serves as an Assistant Professor at both the Joan and Sanford I. Weill Medical College Department of Medicine, Cornell University, New York Presbyterian Hospital and Memorial Sloan-Kettering Cancer Center, New York, NY. His focus is on the care of patients with lymphoma, with a research sub-specialty interest in the development of new therapies for T-cell and cutaneous lymphomas as well as lymphoproliferative disorders developing in immunosuppressed patients after organ transplant.


Sundar Jagannath, MD

Leukemia, Lymphoma, and Myeloma Oncology Consortium

Dr. Jagannath is Director of the Multiple Myeloma Program at Mount Sinai Hospital’s Tisch Cancer Institute and Professor of Medicine at Icahn School of Medicine, N.Y., N.Y. A board-certified internal medicine and medical oncology specialist, he received his medical degree, Maharaja Sayajirao University, Baroda, India. He completed an immune-virology fellowship at McMaster UMC, Ontario, Canada. His residency was completed at the Bronx-Lebanon Hospital in Bronx, N.Y. and at Harper-Grace Hospital, Wayne State University, Detroit, MI. He completed a medical oncology fellowship at University of Texas System Cancer Center–M.D. Anderson Hospital and Tumor Institute, Houston, TX. He was Professor of Pathology and Medicine, University of Arkansas, where he served as Bone Marrow Transplantation Chief. He was the Bone Marrow Transplant and Multiple Myeloma Program Chief at St. Vincent’s CCC, N.Y., N.Y.


Charles A. Schiffer, MD, PhD

Leukemia, Lymphoma, and Myeloma Oncology Consortium

Charles A. Schiffer, MD, is Professor of Medicine and Oncology at Wayne State University School of Medicine and the Karmanos Cancer Institute in Detroit, Michigan. He is the director of the Leukemia/Lymphoma Multidisciplinary Program. Dr. Schiffer earned his BA cum laude at Brandeis University and his M.D. at New York University School of Medicine. He completed his internship, residency, and chief residency in Internal Medicine at Bellevue Hospital under the auspices of New York University School of Medicine and had subsequent training and positions at the Baltimore Cancer Research Institute, National Cancer Institute and the University of Maryland School of Medicine, where he served as Chief of the Division of Hematology. He has also served as Chief of the Division of Hematology/Oncology and Director of Clinical Research at the Karmanos Cancer Institute.


Richard Stone, MD

Leukemia, Lymphoma, and Myeloma Oncology Consortium

Richard Stone, MD, is the Chief of Staff and Director of the Adult Acute Leukemia Program at Dana-Farber, and Professor of Medicine at Harvard Medical School. Dr. Stone is nationally recognized for his translational and clinical research concerning blood and bone marrow malignancies including acute leukemia, myeloproliferative disorders and myelodysplastic syndrome [MDS] (a bone marrow failure state that may convert to leukemia).


Martin S. Tallman, MD

Leukemia, Lymphoma, and Myeloma Oncology Consortium

Martin S. Tallman, M.D. is Chief, Leukemia Service at Memorial Sloan-Kettering Cancer Center and Professor of Medicine at Weill Cornell Medical College in New York, USA. Previously, he was Professor of Medicine at the Northwestern University Feinberg School of Medicine, USA and Co-Director of the Hematologic Malignancy Program at the Robert H. Lurie Comprehensive Cancer Center of Northwestern University in Chicago, Illinois, USA. He is a diplomate of the American Board of Internal Medicine with sub-specialty certification in the areas of hematology and medical oncology. He serves as Chair of the Leukemia Committee of the Eastern Cooperative Oncology Group.


Andrew D. Zelenetz, MD

Leukemia, Lymphoma, and Myeloma Oncology Consortium

Andrew D. Zelenetz, MD, PhD is the Vice Chair, Medical Informatics in the Department of Medicine at Memorial Sloan-Kettering Cancer Center (MSKCC) in New York. Prior to that, he was Chief, Lymphoma Service in the Division of Hematology/Oncology at MSKCC. He is also Associate Professor of Medicine at Weill Medical College of Cornell University. Dr Zelenetz’s research focuses primarily on improving clinical outcomes in lymphoma and on the molecular mechanisms of non-Hodgkin lymphoma. Throughout his career, his research has been published in such journals as BLOOD, the Journal of Clinical Oncology and Clinical Cancer Research. He received his BA, PhD, and MD from Harvard University. Both his internship and residency were completed at Stanford University as well as a clinical and research fellowship in oncology.

LOC_Cover_Page
Download Capability Slide

Oncology Consortium | All Rights Reserved 2012-2017
Back to Top